跳至主要内容
临床试验/CTRI/2021/01/030461
CTRI/2021/01/030461尚未招募2 期

EFFECT OF GUDUCHI RASAYANA IN THE MANAGEMENT OF MEDOROGA ASSOCIATED WITH HYPOTHYROIDISM

ALL INDIA INSTITUTE OF AYURVEDA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Age- 18-60 years.
  • 2)Patients of both sexes.
  • 3)TSH levels greater than/equal to 4.6 mIU/L to greater than/equal to 19.9 mIU/L with or without thyroxine.
  • 4)Patients having clinical symptoms of Medoroga like- Ashakta sarvakarmasu,kshudra shwasa, trisha ,moha, Swapna, kathana sadana ,kshudha, sweda , daurgandhya, alpa prana, alpa maithuna, udara vriddhi etc.
  • 5)Patients having clinical symptoms of hypothyroidism like - Weakness, Fatigue, Muscle ache, Muscle weakness, Breathlessness, Lethargy, Hoarseness of voice, loss of libido, Menstrual abnormality, Puffiness of the face and eyelids, Peripheral edema, Weight gain, Dry coarse skin, Constipation, Hair loss, Feeling cold.

排除标准

  • 1)Patient having TSH level greater than 19.9 mIU/ L.
  • 2)Recent thyroid surgery or radio-iodine (within 12 months).
  • 3)Uncontrolled blood sugar, hypertension.
  • 4)Prior clinical diagnosis of dementia.
  • 5)Recent acute coronary syndrome, including myocardial infarction or unstable angina.
  • 6)Plan to move out of the region in which the trial is being conducted within the next 2 years (proposed minimum time of study)
  • 7)Suffering from diseases like HIV, tuberculosis, encephalopathy, goiter, other endocrine disorders and other autoimmune disorders.
  • 8)Pregnancy, lactation.
  • 9)Any other condition/medication which interfere with the intervention.

研究者

相似试验